SLNCF — Silence Therapeutics Share News
0.000.00%
- $906.79m
- $714.03m
- £25.38m
- 63
- 11
- 57
- 40
REG - Silence Therapeutics - Change to Executive Leadership Team
AnnouncementREG - Silence Therapeutics - Additional Listing and Total Voting Rights
AnnouncementREG - Silence Therapeutics - Conference Participation
AnnouncementREG - Silence Therapeutics - Holding(s) in Company
AnnouncementREG - Silence Therapeutics - Second Price Monitoring Extn
AnnouncementREG - Silence Therapeutics - Price Monitoring Extension
AnnouncementREG - Silence Therapeutics - Second Price Monitoring Extn
AnnouncementREG - Silence Therapeutics - Price Monitoring Extension
AnnouncementREG - Silence Therapeutics - 2020 interim results
AnnouncementREG - Silence Therapeutics - Silence Therapeutics announces new CEO
AnnouncementREG - Silence Therapeutics - Grant of options
AnnouncementREG - Silence Therapeutics - R&D update
AnnouncementREG - Silence Therapeutics - Completion of Nasdaq listing
AnnouncementREG - Silence Therapeutics - Instructions exchanging ordinary shares for ADSs
AnnouncementREG - Silence Therapeutics - Holding(s) in Company
AnnouncementREG - Silence Therapeutics - Holding(s) in Company
AnnouncementREG - Silence Therapeutics - Silence to Participate in US Investor Conferences
AnnouncementREG - Silence Therapeutics - Silence Therapeutics Notice of Results
AnnouncementREG - Silence Therapeutics - Silence Therapeutics Files Registration with SEC
Announcement